Concepedia

Author

Cheryl A. Corbett

University of RochesterORCID

Also Known As

C Corbett, C.A. Corbett, Cheryl A Corbett, Cheryl A. Corbett, Cheryl Corbett

64

Publications

1.5K

Citations

14

H-Index

43

Concepts

All Affiliations

University of RochesterBrigham Young UniversityCornell UniversityUniversity of Colorado DenverUniversity of Kentucky
CA

About

Cheryl A. Corbett is an author at University of Rochester specializing in medicine, maternal health, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

300

2

Education

1

1

13

3

Language Studies

1

1

13

4

Natural Sciences

1

1

43

5

Nursing

1

1

65

Cheryl A. Corbett

×

14

Publications

1.4K

Citations

13

H-Index

YearCitations

An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells

Mónica L. Guzmán, Randall M. Rossi, Sundar Neelakantan,

Blood

2007

407

Targeting Aberrant Glutathione Metabolism to Eradicate Human Acute Myelogenous Leukemia Cells

Shanshan Pei, Mohammad Minhajuddin, Kevin P. Callahan,

Journal of Biological Chemistry

2013

196

Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data

Duane C. Hassane, Mónica L. Guzmán, Cheryl A. Corbett,

Blood

2008

189

Postpartum Depression and Help‐Seeking Behaviors in Immigrant Hispanic Women

Lynn Clark Callister, Renea L. Beckstrand, Cheryl A. Corbett

Journal of Obstetric, Gynecologic & Neonatal Nursing

2011

153

Rapid and selective death of leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)

Mónica L. Guzmán, Xiaojie Li, Cheryl A. Corbett,

Blood

2007

108

Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways

Duane C. Hassane, Siddhartha Sen, Mohammad Minhajuddin,

Blood

2010

76

Nursing Support during Labor

Cheryl A. Corbett, Lynn Clark Callister

Clinical Nursing Research

2000

65

Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia

Mónica L. Guzmán, Neng Yang, Krishan K. Sharma,

Molecular Cancer Therapeutics

2014

55

Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity

Siddhartha Sen, Duane C. Hassane, Cheryl A. Corbett,

Experimental Hematology

2013

43

Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity

Kevin P. Callahan, Mohammad Minhajuddin, Cheryl A. Corbett,

Leukemia

2014

39

Page 1